p16 loss of expression in melanoma tissue was found in 10 out of 14 (71%) CDKN2A germline mutated cases, as compared to 45 out of 73 (62%) CDKN2A wild type cases, but this difference was not statistically significant (p = 0.559, Table 1). Here, CDKN2A is linked to melanoma.